CVS Separation Reverses Years Of Integration

CVS Health plans to divide itself into two companies, undoing much of the corporate integration that helped reshape American healthcare. Its proposed separation would distinguish the retail pharmacy business from insurance and other healthcare services.

The company expects to complete the split in the first half of 2028, subject to the necessary steps and approvals. The strategy follows growing scrutiny of businesses that control several stages of the healthcare supply chain, from insurance coverage to prescriptions.

Supporters of integration argue that combining services can improve coordination and reduce costs. Critics question whether ownership across different parts of the market may create conflicts of interest or reduce competition. Separation does not by itself settle those disputes.

For corporate governance, CVS represents a significant reversal of a once-dominant strategic assumption that scale and integration invariably produce stronger businesses. The eventual test will be whether more focused companies can deliver better operations, accountability and outcomes for patients and investors.